€14.1m loss for AGI

AGI Therapeutics has today reported audited financial results for the twelve months ended December 31 2007, inlcuding a net loss of €14.1m)

Other highlights included: Revenue of €392,000, cash and short term deposits at €30.9 m, R&D spend of €13.2m.